FDA updates antimicrobial resistance monitoring system

摘要

The US FDA has given a makeover to the National Antimicrobial Resistance Monitoring System (NARMS).The FDA stated: "The overall trend continues to indicate ongoing efforts to support antimicrobial stewardship are having an impact. Sales in 2018 are down 21% since 2009, the first year of reporting, and down 38% since 2015, the peak year of sales and distribution."Tetracyclines represented the largest volume of domestic sales (around 3.97 million kilograms) in 2018 - up 12% from 2017.